Skip links

Altimetrik (US) Designated as a Great Place to Work-Certified™ Company

Jump To Section

Altimetrians are always proud to boast that Altimetrik is a great place to work, and now we have the proof to back up that claim. Altimetrik’s U.S. business was recently honored to be named a Great Place to Work-Certified™ organization.

Altimetrik: Certified Great Workplace!

Altimetrians are always proud to boast that Altimetrik is a great place to work, and now we have the proof to back up that claim. Altimetrik’s U.S. business was recently honored to be named a Great Place to Work-Certified™ organization. Certification is a significant achievement and not one that is easy to get. While this is the first year for our U.S. business, our India business has been Great Place to Work-Certified for four consecutive years. We are justly proud of both achievements.

As an organization, we are always striving to create an empowering and friendly atmosphere for our employees that inspires great work. Our employee experience is a priority, and it is a great acknowledgement to see 82% have reported a consistently positive experience with their coworkers, their leaders, and their jobs. That’s quite a feat when only 59% of employees would say that of the typical U.S. company! In fact, the company had very high ratings across the board in several important categories:

Source: Great Place to Work® 2019 U.S. National Employee Engagement Study

Altimetrik: Building a High-Trust, High-Performance

Great Place to Work is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue and increased innovation. Altimetrik has earned this recognition for creating a Great Place to Work for all employees and has excelled at the key dimensions of building a high-trust, high-performance culture, including:


Hiring and developing great people is a core value for us at Altimetrik and is a key part of our competitive edge as a company. We know that when our employees have a high-trust experience every day they are more productive, drive better business results, and make a difference to our customers.

This certification shows that we can be ranked among the best of the best. Thanks to everyone for helping make this certification possible, because it truly is an achievement that belongs to all of us.

Picture of Sandy Patel

Sandy Patel

Latest Reads


Suggested Reading

Ready to Unlock Your Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes